Southampton
The Southampton ECMC takes science directly from our laboratories into the clinic, particularly in field of immunotherapy. Southampton ECMC aims to build upon its expertise in immunotherapy, uniting both laboratory and clinical research teams to develop novel treatments for both solid and haematological cancers. Southampton has medical imaging, cellular therapy and radiopharmacy facilities and hosts a fully Human Tissue Association (HTA) accredited tissue bank.
Clinical Focus Area
- Medical Oncology, Haematology:
- Surgery:
- Cancer Genetics
- Molecular Pathology
Scientific Focus Area
- Immunotherapy, vaccines, antibodies, Radioimmunotherapy
- Tumour microenvironment
- Biomarkers, prognostic and predictive
- Molecular diagnostics
Disease Focus Area
| Colorectal | Laryngeal | leukaemia | Melanoma |
| Myeloma | Neuroblastoma | Non-Hodgkin's Lymphoma | Oesophageal |
| Oral Cavity and Lip | Prostate | Thyoma |
Goals
Skills
Southampton ECMC principal investigators and staff have a range of skills and expertise.
Facilities
Southampton ECMC has access to a range of research facilities that are utilised in studies.
Increase text
Decrease text
Print this page